Get App Journal Flyer

Total Page：16

File Type：pdf, Size：1020Kb

IMPACT FACTOR 6.639 an Open Access Journal by MDPI The Irish Association for Cancer Research (IACR), Signal Transduction Society (STS) and Spanish Association for Cancer Research (ASEICA) are affiliated with Cancers. IMPACT FACTOR 6.639 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof. Dr. Samuel C. Mok Cancers is an international, online journal addressing both clinical and basic science issues related to cancer Associate Editors Prof. Dr. David Wong research. The journal will continue its open access Dr. Deepak Nagrath format, which will certainly evolve to ensure that the Prof. Dr. Mary Frances McMullin journal takes full advantage of the rapidly changing world of information and knowledge dissemination. It publishes high-quality clinical, translational, and basic science research on cancer prevention, initiation, progression, and treatment, as well as other related topics, particularly to capture the most seminal studies in the rapidly growing area of immunology, immunotherapy, and tumor microenvironment. Author Benefits Open Access Unlimited and free access for readers No Copyright Constraints Retain copyright of your work and free use of your article Thorough Peer-Review Rapid Processing and Immediate Publication upon Acceptance Coverage by Leading Indexing Services SCIE-Science Citation Index Expanded (Clarivate Analytics), PubMed (NLM), Scopus (Elsevier) No Space Constraints, No Extra Space or Color Charges No restriction on the length of the papers, number of figures or colors Discounts on Article Processing Charges (APC) If you belong to an institute that participates with the MDPI Institutional Open Access Program (IOAP) Aims and Scope Cancers features (1) Original Articles reporting on novel and original findings; (2) Clinical Observations accompanied by analysis and discussion; (3) Communications reporting small scale studies that include important new information; (4) timely Reviews and Topical Issues on cutting edge fields in oncology. In addition, we accept well-designed studies showing meaningful but negative results. By doing this, we encourage scientists to share those data so that they would not need to repeat the experiments that somebody else has already done. The scope of Cancers includes (but is not limited to): Cancer pathophysiology Cancer causes Cancer diagnosis Cancer screening Cancer prognosis Cancer prevention, initiation, progression, and treatment Editorial Office Cancers Editorial Office [email protected] MDPI, St. Alban-Anlage 66 4052 Basel, Switzerland Tel: +41 61 683 77 34 Fax: +41 61 302 89 18 www.mdpi.com mdpi.com/journal/cancers MDPI is a member of Affiliated Societies Follow Us facebook.com/MDPIOpenAccessPublishing twitter.com/@Cancers_MDPI linkedin.com/company/mdpi weibo.com/mdpicn Wechat: MDPI-China blog.mdpi.com www.mdpi.com mdpi.com/journal/cancers See www.mdpi.com for a full list of offices and contact information. MDPI is a company registered in Basel, Switzerland, No. CH-270.3.014.334-3, whose registered office is at St. Alban-Anlage 66, CH-4052 Basel, Switzerland. Basel, July 2021.

Copy Link

Recommended publications

Current Problems in Cancer: Case Reports
CURRENT PROBLEMS IN CANCER: CASE REPORTS AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.10 ISSN: 2666-6219 DESCRIPTION . Current Problems in Cancer: Case Reports is an international, peer-reviewed open access Journal which aims to fortify the field of oncology by publishing original case reports featuring prevention, diagnosis and treatment of cancer, supportive care, quality of life and rehabilitation. A companion title to Current Problems in Cancer, the Journal provides a global forum for clinicians and researchers to share their personal experiences through case reports, striving to inform clinical cancer research and care. ABSTRACTING AND INDEXING . Directory of Open Access Journals (DOAJ) EDITORIAL BOARD . Editor-in-Chief Nam Quoc Bui, Stanford University School of Medicine, Stanford, California, United States of America Area of Expertise: Sarcoma, Developmental Therapeutics Associate Editors Satya (Nanu) Das, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States of America Areas of Expertise: Gastrointestinal Oncology, Phase I, Drug Development Sunil A. Reddy, Stanford University, Stanford, California, United States of America Cutaneous Oncology , Evidence-Based Medicine, Lymphoma Kay T. Yeung, University of California San Diego Moores Cancer Center, La Jolla, California, United States of America Breast oncology Lisa C. Zaba, Stanford University School of Medicine, Stanford, California, United States of America Supportive Onco-dermatology, melanoma, merkel cell Advisory Reviewer Board Carlos A Alarcón Rojas, Veracruzana University, Xalapa, Mexico Cancer, Epidemiology, Survival, Biostatistics Syed Muhammad Ali, Weill Cornell Medicine - Qatar, Doha, Qatar General and Colorectal Surgery Moustafa Alkhalil, Hamad Medical Corporation, Doha, Qatar head and neck cancer AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/cpccr 1 Fernando A.
[Show full text]
PCHHAX Overview of Flaxseed Patent
Available online a t www.derpharmachemica.com ISSN 0975-413X Der Pharma Chemica, 2016, 8(14):33-38 CODEN (USA): PCHHAX (http://derpharmachemica.com/archive.html) Overview of Flaxseed Patent Applications for the prevention and treatment of human cancer Sepideh Miraj Infertility Fellowship, Medicinal Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran _____________________________________________________________________________________________ ABSTRACT Flaxseed, Linum usitatissimum, is a member of the genus Linum in the family Linaceae. It is a food and fiber crop cultivated in cooler regions of the world. The aim of this study is to overview its anti-cancer and anti-tumor effects. This review article was carried out by searching studies in PubMed, Medline, Web of Science, and IranMedex databases up to 2016.totally, of 1 08 found articles, 41 articles were included. The search terms were “Flaxseed. ”, “therapeutic”, “pharmacological”, anticancer, anti-tumor. Various studies have shown that Flaxseed. Possess Anti-Breast Cancer properties, Anti-Breast tumors properties , Anti-Ovary cancer properties, Gut-associated diseases properties, Lung tumor properties, Inflammation properties, Anti-Skin Carcinogenesis properties, Pro- carcinogenic, Mastalgia properties, Aortic remodeling ,Anti-mammary Cancer effect ,Antioxidant and Antiproliferative ,Colon cancer properties, Esophagitis properties, Apoptosis properties. Flaxseed possess lots of therapeutic and pharmacological effects.in this study, its anticancer, anti-tumor effects was overviewed. Keywords : Flaxseed, therapeutic, pharmacological, anticancer, anti-tumor. _____________________________________________________________________________________________ INTRODUCTION It is proved that herbal medicine is effective in the treatment of many diseases [1-10].Flax, Linum usitatissimum , is a member of the genus Linum in the family Linaceae. It is a food and fiber crop cultivated in cooler regions of the world.
[Show full text]
A Bibliometric Analysis
787 Original Article Page 1 of 9 The 100 most cited articles on lung cancer screening: a bibliometric analysis Meng Li1,2, Qiang Cai2,3, Jing-Wen Ma1, Li Zhang1,2, Claudia I. Henschke2 1Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 2Department of Radiology, Mount Sinai Health System, New York, NY, USA; 3Department of Radiology, Shanxi Provincial People’s Hospital, Taiyuan, China Contributions: (I) Conception and design: M Li, CI Henschke; (II) Administrative support: CI Henschke; (III) Provision of study materials or patients: M Li, CI Henschke; (IV) Collection and assembly of data: M Li, L Zhang; (V) Data analysis and interpretation: M Li, Q Cai, JW Ma; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Claudia I. Henschke. Department of Radiology, Mount Sinai Health System, 1 Gustave Levy Place, New York, NY 10029, USA. Email: [email protected]. Background: The number of citations of an article reflects its impact on the scientific community. The aim of this study was to identify and characterize the 100 most cited articles on lung cancer screening. Methods: The 100 most cited articles on lung cancer screening published in all scientific journals were identified using the Web of Science database. Relevant data, including the number of citations, publication year, publishing journal and impact factor (IF), authorship and country of origin, article type and study design, screening modality, and main topic, were collected and analyzed. Results: The 100 most cited articles were all English and published between 1973 and 2017, with 81 published after 2000.
[Show full text]
Cancer Treatment and Survivorship Facts & Figures 2019-2021
Cancer Treatment & Survivorship Facts & Figures 2019-2021 Estimated Numbers of Cancer Survivors by State as of January 1, 2019 WA 386,540 NH MT VT 84,080 ME ND 95,540 59,970 38,430 34,360 OR MN 213,620 300,980 MA ID 434,230 77,860 SD WI NY 42,810 313,370 1,105,550 WY MI 33,310 RI 570,760 67,900 IA PA NE CT 243,410 NV 185,720 771,120 108,500 OH 132,950 NJ 543,190 UT IL IN 581,350 115,840 651,810 296,940 DE 55,460 CA CO WV 225,470 1,888,480 KS 117,070 VA MO MD 275,420 151,950 408,060 300,200 KY 254,780 DC 18,750 NC TN 470,120 AZ OK 326,530 NM 207,260 AR 392,530 111,620 SC 143,320 280,890 GA AL MS 446,900 135,260 244,320 TX 1,140,170 LA 232,100 AK 36,550 FL 1,482,090 US 16,920,370 HI 84,960 States estimates do not sum to US total due to rounding. Source: Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute. Contents Introduction 1 Long-term Survivorship 24 Who Are Cancer Survivors? 1 Quality of Life 24 How Many People Have a History of Cancer? 2 Financial Hardship among Cancer Survivors 26 Cancer Treatment and Common Side Effects 4 Regaining and Improving Health through Healthy Behaviors 26 Cancer Survival and Access to Care 5 Concerns of Caregivers and Families 28 Selected Cancers 6 The Future of Cancer Survivorship in Breast (Female) 6 the United States 28 Cancers in Children and Adolescents 9 The American Cancer Society 30 Colon and Rectum 10 How the American Cancer Society Saves Lives 30 Leukemia and Lymphoma 12 Research 34 Lung and Bronchus 15 Advocacy 34 Melanoma of the Skin 16 Prostate 16 Sources of Statistics 36 Testis 17 References 37 Thyroid 19 Acknowledgments 45 Urinary Bladder 19 Uterine Corpus 21 Navigating the Cancer Experience: Treatment and Supportive Care 22 Making Decisions about Cancer Care 22 Cancer Rehabilitation 22 Psychosocial Care 23 Palliative Care 23 Transitioning to Long-term Survivorship 23 This publication attempts to summarize current scientific information about Global Headquarters: American Cancer Society Inc.
[Show full text]
Integrative Oncology from a Bibliometric Point of View T Jenny-Ann Brodin Danell
Complementary Therapies in Medicine 52 (2020) 102477 Contents lists available at ScienceDirect Complementary Therapies in Medicine journal homepage: www.elsevier.com/locate/ctim Integrative oncology from a bibliometric point of view T Jenny-Ann Brodin Danell Department of Sociology, Umeå University, 901 87 Umeå, Sweden ARTICLE INFO ABSTRACT keywords: Objectives: The aim of this article is to analyze the development of integrative oncology from a bibliometric point Integrative oncology of view. The publication and citation patterns of publications are analyzed and their contents mapped. Complementary therapies Design: This study is based on bibliometric methods. The data sets consist of 7 025 respectively 4 990 pub- Research domain lications over the time period 1966-2016, shown in PubMed and Web of Science. Bibliometric methods Results: The expansion of the numbers of these publications took place in the late 1990s/early 2000s. Research is Citation analysis dominated by authors located in the USA, China and Germany who are working at well-established research Content analysis universities and university hospitals. The clinical share of publications is relatively small, and few studies are classified according to clinical phase. Content analysis revealed that much of the clinical research is based on surveys, and that content reflects the intersection of complementary therapies and cancer research. The latter aspect is less obvious in pre-clinical research. The most frequent journals in the material show a focus on complementary and alternative therapies or on integrative oncology, although journals focused on oncology or general/internal medicine were well-represented in the material as a whole. The most-cited publications were review articles and surveys.
[Show full text]
An American Cancer Society Guide for Informed Choices Downloaded from Colleen Doyle, MS, RD; Lawrence H
Downloaded from Nutrition and Physical Activity During and After Cancer Treatment: An American caonline.amcancersoc.org Cancer Society Guide for Informed Choices Colleen Doyle, Lawrence H. Kushi, Tim Byers, Kerry S. Courneya, Wendy Demark-Wahnefried, Barbara Grant, Anne McTiernan, Cheryl L. Rock, Cyndi Thompson, Ted Gansler, Kimberly S. Andrews and for the 2006 Nutrition, Physical Activity and Cancer Survivorship Advisory Committee CA Cancer J Clin 2006;56;323-353 DOI: 10.3322/canjclin.56.6.323 by on August 5, 2009 (©American Cancer Society, Inc.) This information is current as of August 5, 2009 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://caonline.amcancersoc.org/cgi/content/full/56/6/323 To subscribe to the print issue of CA: A Cancer Journal for Clinicians, go to (US individuals only): http://caonline.amcancersoc.org/subscriptions/ CA: A Cancer Journal for Clinicians is published six times per year for the American Cancer Society by Wiley-Blackwell. A bimonthly publication, it has been published continuously since November 1950. CA is owned, published, and trademarked by the American Cancer Society, 250 Williams Street NW, Atlanta GA 30303. (©American Cancer Society, Inc.) All rights reserved. Print ISSN: 0007-9235. Online ISSN: 1542-4863. CA Cancer J Clin 2006;56:323–353 Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices Downloaded from Colleen Doyle, MS, RD; Lawrence H. Kushi, ScD; Tim Byers, MD, MPH; Ms. Doyle is Director, Nutrition and Kerry S. Courneya, PhD; Wendy Demark-Wahnefried, PhD, RD, LDN; Barbara Grant, MS, Physical Activity, American Cancer Society, Atlanta, GA.
[Show full text]
Myeloid-Derived Suppressor Cells in Gastrointestinal Cancers: a Systemic Review
Thomas Jefferson University Jefferson Digital Commons Division of Internal Medicine Faculty Papers & Presentations Division of Internal Medicine 1-15-2021 Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review. Maham Farshidpour Monjur Ahmed Shilpa Junna Juanita L. Merchant Follow this and additional works at: https://jdc.jefferson.edu/internalfp Part of the Internal Medicine Commons Let us know how access to this document benefits ouy This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Division of Internal Medicine Faculty Papers & Presentations by an authorized administrator of the Jefferson Digital Commons. For more information, please contact: [email protected]. ISSN 1948-5204 (online) World Journal of Gastrointestinal Oncology World J Gastrointest Oncol 2021 January 15; 13(1): 1-91 Published by Baishideng Publishing Group Inc World Journal of Gastrointestinal W J G O Oncology Contents Monthly Volume 13 Number 1 January 15, 2021 THERAPEUTIC AND DIAGNOSTIC GUIDELINES
[Show full text]
Translational Oncology
TRANSLATIONAL ONCOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.22 ISSN: 1936-5233 DESCRIPTION . Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials. IMPACT FACTOR . 2020: 4.243 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . PubMed/Medline Scopus Directory of Open Access Journals (DOAJ) EDITORIAL BOARD . Co-Editors-in-Chief Bushra Ateeq, Indian Institute of Technology Kanpur, Kanpur, India Genetic/epigenetic alterations in prostate cancer, Cancer Biomarkers and Drug Targets, Mechanism of Drug resistance, non-coding RNAs in cancer. Justin Durla Lathia, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio, United States of America Cancer stem cells, Glioblastoma, Cell-Cell Communication, Adhesion, Sex Differences Caroline E. Nunes-Xavier, Radium Hospital Institute for Cancer Research, Oslo, Norway Immune checkpoint proteins, Immunotherapy, Protein tyrosine phosphatase Günter Schneider, University Medical Center Göttingen, , Germany Analysis of signaling, cell cycle regulation, transcriptional regulation, and apoptosis, Molecular biology of GI-cancers Yu Sun, Chinese Academy of Sciences Shanghai Institute of Nutrition and Health, Shanghai, China Cancer Resistance, Tumor Microenvironment, Cellular Senescence, Aging and Age-related diseases, , Verna D.N.K.
[Show full text]
Print Special Issue Flyer
IMPACT FACTOR 6.639 an Open Access Journal by MDPI Prostate Cancer: Past, Present, and Future Guest Editor: Message from the Guest Editor Prof. Dr. Ajay Pratap Singh This Special Issue of the Cancers (2017 Impact Factor: Cancer Biology Program, Mitchell 5.326) will cover all aspects of prostate cancer, which is the Cancer Institute, University of most common non-cutaneous malignancy among men, South Alabama, Mobile, AL 36604, USA with nearly 1.3 million new cases diagnosed globally in asingh@ 2018. This Special Issue intends to publish emerging data, health.southalabama.edu expert opinions, and reviews to add to the growing knowledge base, and to derive meaningful interpretations from available research and clinical insights in scientific literature. Deadline for manuscript submissions: A broad range of studies on prostate cancer (research, closed (15 November 2019) clinical, outreach, and public health) will be considered for inclusion in this Special Issue. We encourage you to submit original, empirical studies as well as systematic reviews or meta-analyses. Short reports and methodological papers will also be considered. Especially, we encourage the submission of interdisciplinary work and multi-country collaborative research. Keywords Prostate cancer Cancer health disparities Molecular pathogenesis Tumor microenvironment Prevention and control Biomarkers Treatments mdpi.com/si/25111 SpeciaIslsue IMPACT FACTOR 6.639 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof. Dr. Samuel C. Mok Cancers is an international online journal addressing both Department of Gynecologic clinical and basic science issues related to cancer research. Oncology and Reproductive The journal is publishing in Open Access format, which will Medicine, The University of Texas MD Anderson Cancer Center, certainly evolve to ensure that the journal takes full Houston, TX 77030, USA advantage of the rapidly changing world of information and knowledge dissemination.
[Show full text]
What Is the Relay for Life Movement? Join the W Orldwide
What is the Relay For Life movement? Join the worldwide movement to end cancer. end to movement worldwide Join the Each American Cancer Society Relay For Life event gives everyone an opportunity to fight cancer and help save more lives. Teams made up of family members, friends, and/or coworkers camp out at a local school, park, or fairground and take turns walking American Cancer Society Relay For Life | RelayForLife.org 1.800.227.2345 around a track or path. Because cancer never sleeps, each team is asked to have a representative on the track at all times during the overnight event. Relay For Life is the signature fundraising event for the American Cancer Society. At the event, you will have the opportunity to celebrate cancer survivors, remember loved ones lost to the disease, and learn more about how to fight back against cancer. While you’re raising much-needed funds, you’ll also be raising awareness of the importance of cancer prevention, early detection, treatment, and patient support. Celebrate Survivors and Caregivers At Relay For Life events, cancer survivors and caregivers can come together and be recognized for their personal fight against a disease that has taken too much. In addition to a special ceremony, Survivors and Caregivers laps open the event and serve as a testament to the fight against cancer and the hope for a cure. All survivors and caregivers are invited to join their local Relay For Life event, no matter where their personal journey with cancer has taken them. Remember during the Luminaria Ceremony When the sun goes down, luminaria line the track, each one lit in honor or memory of those who have faced cancer – those who lost their battle, those who won, and those whose fight continues.
[Show full text]
Specialissue
IMPACT FACTOR 6.639 an Open Access Journal by MDPI Prognostic and Predictive Markers in Pancreatic Cancer Guest Editors: Message from the Guest Editors Dr. Eugene J. Koay Dear Colleagues, Department of Radiation Oncology, University of Texas MD Significant progress has been made in the understanding Anderson Cancer Center, of the biological underpinnings of pancreatic cancer in Houston, TX 77030, USA recent years. Coupled with this progress, multiple groups [email protected] have identified biomarkers that may aid in our early Dr. Aatur D. Singhi detection of the disease, personalization of therapy for Department of Pathology, patients, measurement of treatment response, and University of Pittsburgh Medical imaging of the cancer. Such biomarkers have been Center, Pittsburgh, PA 15232, USA identified in a wide array of information sources, including [email protected] but not limited to tissue, blood, urine, imaging, electronic health records, and internet search data. We invite you to share your work related to biomarkers of pancreatic cancer Deadline for manuscript in this special issue of Cancers. submissions: closed (31 August 2021) Dr. Eugene J. Koay Dr. Aatur D. Singhi Guest Editors mdpi.com/si/65604 SpeciaIslsue IMPACT FACTOR 6.639 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof. Dr. Samuel C. Mok Cancers is an international online journal addressing both Department of Gynecologic clinical and basic science issues related to cancer research. Oncology and Reproductive The journal is publishing in Open Access format, which will Medicine, The University of Texas MD Anderson Cancer Center, certainly evolve to ensure that the journal takes full Houston, TX 77030, USA advantage of the rapidly changing world of information and knowledge dissemination.
[Show full text]
Download This PDF File
Journal of Tumor Online Submissions: http: //www.ghrnet.org/index.php/jt Journal of Tumor 2021 May; 9(1): 579-586 DOI: 10.17554/j.issn.1819-6187.2021.09.130 ISSN 1819-6187 ORIGINAL ARTICLE Global Scientific Research Progress in Thyroid Cancer: A Bibliometric Analysis Hassan H. Musa1,2, Idriss H. Musa1,3, Mansour El-Sharief2, Taha H. Musa1,3,4* 1 Biomedical Research Institute, Darfur College, Nyala, Sudan; supported 25.68% of TC research. Journal of thyroid and journal 2 Faculty of Medical Laboratory Sciences, University of Khartoum, of clinical endocrinology and metabolism are the most productive Khartoum, Sudan; journals. Wang Y and Tuttle RM were the top productive, authors. 3 School of Medicine, Darfur College, Nyala, Sudan; Revised American thyroid association management guidelines for 4 Organization of African Academic Doctor (OAAD), Off Kamiti patients with thyroid nodules and differentiated thyroid cancer authored Road, P.O Box 25305000100, Nairobi, Kenya. by Cooper DS et al., published in 2009, was the most cited article. The most retrieved keywords were thyroid cancer, papillary thyroid cancer, Conflict-of-interest statement: The author(s) declare(s) that there and differentiated thyroid cancer. The study concludes that USA is no conflict of interest regarding the publication of this paper. institutes and funding agencies contribute to thyroid cancer research at a global level. Papillary thyroid cancer is a hot topic for research. Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external Key words: Thyroid cancer; Bibliometrics; Scopus; Web of Science reviewers.
[Show full text]